Local Institution - 700
Kōtoku 1350063
0 studies enrolling now · 1 studies all time
What they study most
Lymphoma, Non-Hodgkin
Studies at this site
Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)
— Completed